Year: 2024
Type: conference-paper
Abstract: Preliminary results on MS patient seraConclusions and future perspectives MOG is known to be an encephalitogenic protein that can elicit a demyelinating immune response in numerous experimental models of inflammatory demyelinating diseases.Conflicting results have been obtained when using full-length MOG in ELISAs to test MS patient sera.
Source: European Peptide Symposium (EPS)
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funder: European Commission
Awards: G1115267702, G7399917317
OpenAlex ID: W4402942174